Form 990 for tax year 2024
Filed by COMMONWEALTH FOUNDATION FOR CANCER RESEARCH FOUNDATION.
Totals
- Total revenue
- $25,046,690
- Total expenses
- $55,998,011
- Contributions and grants received
- $20,840,729
- Grants paid
- $55,912,005
- Program service revenue
- $0
- Investment income
- $4,205,194
- Other revenue
- $767
- Total assets, end of year
- $50,949,327
- Total liabilities, end of year
- $96,958
- Net assets or fund balances, end of year
- $50,852,369
- Program services expenses (Part IX)
- $55,912,005
- Management and general expenses
- $86,006
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $55,912,005
Program services were 99.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$20,840,729
-
3 · Investment income
total $2,628,222 · excluded $2,628,222
-
6a · Gross rents
real property $10,000
-
6b · Less rental expenses
real property $2,581
-
6c · Rental income or loss
real property $7,419
-
6d · Net rental income or loss
total $7,419 · excluded $7,419
-
7a · Gross sales of assets other than inventory
securities $75,803,462 · other assets $1,940,163
-
7b · Less cost or other basis and sales expenses
securities $75,799,767 · other assets $366,886
-
7c · Gain or loss
securities $3,695 · other assets $1,573,277
-
7d · Net gain or loss
total $1,576,972 · excluded $1,576,972
-
11a · Other revenue: NET INCOME FROM INVEST
total -$6,652 · excluded -$6,652
-
11e · Other revenue, total
-$6,652
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $55,912,005 · program services $55,912,005
-
5 · Compensation of officers, directors and key employees
total $27,500 · management and general $27,500
-
11c · Fees: accounting
total $9,000 · management and general $9,000
-
24a · Other expenses: REAL ESTATE TAXES
total $37,585 · management and general $37,585
-
24b · Other expenses: ASSOCIATION DUES AND LO
total $8,526 · management and general $8,526
-
24c · Other expenses: BROKERAGE FEES
total $2,683 · management and general $2,683
-
24d · Other expenses: MAINTENANCE
total $684 · management and general $684
-
24e · All other expenses
total $28 · management and general $28
Balance sheet
Part X, book values.
-
2 · Savings and temporary cash investments
beginning of year $1,302,586 · end of year $816,082
-
7 · Other notes and loans receivable
beginning of year $4,560,047 · end of year $4,259,345
-
10a · Land, buildings and equipment: cost or other basis
$4,930,984
-
10c · Land, buildings and equipment, net
beginning of year $5,146,600 · end of year $4,930,984
-
11 · Investments: publicly traded securities
beginning of year $58,491,534 · end of year $28,544,191
-
12 · Investments: other securities
beginning of year $12,397,725 · end of year $12,397,725
-
15 · Other assets
beginning of year $1,000 · end of year $1,000
-
17 · Accounts payable and accrued expenses
beginning of year $95,802 · end of year $96,958
-
29 · Capital stock, trust principal or current funds
beginning of year $0 · end of year $0
-
30 · Paid-in or capital surplus, or land, building or equipment fund
beginning of year $0 · end of year $0
-
31 · Retained earnings, endowment or other funds
beginning of year $81,803,690 · end of year $50,852,369
Mission and programs · 2024
Mission
TO PROVIDE FUNDING FOR CANCER RESEARCH
-
THE CORPORATION IS AN EXEMPT ORGANIZATION UNDER SEC. 501(C)(3) OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED. THE ORGANIZATION PROVIDES SUPPORT FOR IMPROVING CARE AND ADVANCING DISCOVERIES AND NEW TECHNOLOGIES RELATING TO CANCER THROUGH CLINICAL STUDIES AND TRIALS.
Expenses $55,854,555 · Grants $55,854,555
-
THE CORPORATION IS ORGANIZED AS A SUPPORTING ORGANIZATION FOR THE CHARITABLE, SCIENTIFIC AND EDUCATIONAL PURPOSES OF THE COMMUNITY FOUNDATION, INC., AN EXEMPT ORGANIZATION UNDER SEC. 501(C)(3) OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED.
Expenses $57,450 · Grants $57,450
As filed on the 2024 return.
Listed in Part VII
-
William H Goodwin JrWILLIAM H GOODWIN JR
DIRECTOR, PRESIDENT
- Total calculated
- $0
- Hours/week
- 0.5
-
Alice T GoodwinALICE T GOODWIN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.5
-
Wayne L HunterWAYNE L HUNTER
DIRECTOR, TREASURER
- Total calculated
- $12,500
- From this org
- $12,500
- From related orgs
- $0
- Other
- $0
- Hours/week
- 0.5
-
John Sherman JrJOHN SHERMAN JR
DIRECTOR, SECRETARY
- Total calculated
- $15,000
- From this org
- $15,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 0.5
-
James A JonesJAMES A JONES
TAX OFFICER
- Total calculated
- $0
- Hours/week
- 0.5
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
-
COMMONWEALTH CANCER CONSORTIUM INC
$27,110,000
SUPPORT FOR MULTI-INSTITUTIONAL RESEARCH IN CANCER INDICATIONS
-
MEMORIAL SLOAN-KETTERING CANCER CENTER
$8,000,000
SUPPORT PROGRESS IN DRUG DISCOVERY AND DEVELOPMENTAL RESEARCH AGAINST CANCER
-
SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER
$8,000,000
SUPPORT FOR RESEARCHERS AND CLINCIANS TO ADVANCE THE STATE OF CANCER SCIENCE
-
MD ANDERSON CANCER CENTER
$7,500,000
SUPPORT PROGRESS IN IMPROVING CARE FOR OUR PATIENTS WITH CANCER
-
DANA-FARBER CANCER INSTITUTE INC
$2,500,000
SUPPORT FOR CLINICAL STUDIES AND TO ADVANCE DISCOVERIES AND NEW TECHNOLOGIES IN CANCER RESEARCH
-
SUPPORT FOR CLINICAL STUDIES AND TO ADVANCE DISCOVERIES AND NEW TECHNOLOGIES IN CANCER RESEARCH
-
MASSEY CANCER CENTER
$242,186
SUPPORT FOR CLINICAL TRIALS IN CANCER RESEARCH
-
$57,450
UNRESTRICTED SUPPORT
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
501(C)(3) · WORK WITH DONORS/COMMUNITY PARTNERS TO BUILD PHILANTHROPY IN RICHMOND VA · VA
-
501(C)(3) · GRANTMAKING · VA · controlled entity
Directly controlled by THE COMMUNITY FOUNDATION INC
-
ANNABELLA R JENKINS FOUNDATION
501(C)(3) · GRANTMAKING · VA · controlled entity
Directly controlled by THE COMMUNITY FOUNDATION INC
-
501(C)(3) · GRANTMAKING · VA · controlled entity
Directly controlled by THE COMMUNITY FOUNDATION INC
-
501(C)(3) · GRANTMAKING · VA · controlled entity
Directly controlled by THE COMMUNITY FOUNDATION INC
-
THE JANE AND ARTHUR FLIPPO ENDOWMENT FOUNDATION
501(C)(3) · GRANTMAKING · VA · controlled entity
Directly controlled by THE COMMUNITY FOUNDATION INC
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 13 November 2025
- IRS schema version
- 2024v5.2
- Source object
- 202513179349301331
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.